Astra Zeneca will be starting clinical trials in testing its experimental Covid-19 vaccine with Russia’s Sputnik V shot. This is in the aim of boosting the efficiency of the British drug maker’s vaccine. It was stated in a statement by Russia’s sovereign health fund, which also added that trials will start by the end of the year.
The RDIF has funded Sputnik V, named after the Soviet-era satellite that was the founding bench in the space race. Astra Zeneca added that it was thinking as to how it could assess the combination of the different vaccines. It would soon begin the exploration with Russia’s Gamaleya Institute that developed the Sputnik V.
The research would be based around whether two common cold virus based vaccines could be potentially combined or not. No further details were hence given.